Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury

Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion

Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632

Traffic Signals on Endothelium for Lymphocyte Recirculation and Leukocyte Emigration

Springer, T. A. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004143 · Cited by 1,497

Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion

Imai, T., Hieshima, K., Haskell, C. A., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,472

Role for Neuronally Derived Fractalkine in Mediating Interactions between Neurons and CX3CR1-Expressing Microglia

Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176

Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1413 · Cited by 696

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

Pan, Y., Lloyd, C. M., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J.-Á., Vath, J., Gosselin, M., Ma, J., Dussault, B. J., et al. (1997) · Nature · doi:10.1038/42491 · Cited by 643

Functional and structural diversity of the human Dickkopf gene family

Krupnik, V. E., Sharp, J., Jiang, C., Robison, K. E., Chickering, T. W., Amaravadi, L. S., Brown, D. E., Guyot, D. J., Mays, G. G., Leiby, K. R., et al. (1999) · Gene · doi:10.1016/s0378-1119(99)00365-0 · Cited by 491

Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?

Nishiyori, A., Minami, M., Ohtani, Y., Takami, S., Yamamoto, J., Kawaguchi, N., Kume, T., Akaike, A., & Satoh, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00583-3 · Cited by 365

Fractalkine Cleavage from Neuronal Membranes Represents an Acute Event in the Inflammatory Response to Excitotoxic Brain Damage

Chapman, G. A., Moores, K., Harrison, D. C., Campbell, C. A., Stewart, B. R., & Strijbos, P. J. L. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0004.2000 · Cited by 350

Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin.

Huang, X., Wu, J. F., Cass, D. L., Erle, D. J., Corry, D. B., Young, S. G., Farese, R. V., & Sheppard, D. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.133.4.921 · Cited by 316

Control of microglial neurotoxicity by the fractalkine receptor

Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531

Repertoire of microglial and macrophage responses after spinal cord injury

David, S., & Kroner, A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3053 · Cited by 1,297

The inflammatory response in stroke

Wang, Q., Tang, X. N., & Yenari, M. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.014 · Cited by 1,196

Inflammatory mechanisms in ischemic stroke: therapeutic approaches

Lakhan, S. E., Kirchgessner, A. L., & Hofer, M. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-97 · Cited by 1,097

Modulators of microglial activation and polarization after intracerebral haemorrhage

Lan, X., Han, X., Li, Q., Yang, Q.-W., & Wang, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.69 · Cited by 915

The biphasic function of microglia in ischemic stroke

Ma, Y., Wang, J., Wang, Y., & Yang, G.-Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 655

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

Hundhausen, C., Misztela, D., Berkhout, T. A., BROADWAY, N. M., Säftig, P., Reiß, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V. B., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3775 · Cited by 731

CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models

Lee, S., Varvel, N. H., Konerth, M. E., Xu, G., Cardona, A. E., Ransohoff, R. M., & Lamb, B. T. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100265 · Cited by 522

Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

Cartier, L., Hartley, O., Dubois‐Dauphin, M., & Krause, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 520

Post‐ischemic brain damage: pathophysiology and role of inflammatory mediators

Amantea, D., Nappi, G., Bernardi, G., Bagetta, G., & Corasaniti, M. T. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06766.x · Cited by 473

Bidirectional Microglia–Neuron Communication in Health and Disease

Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459

Role of Inflammation and Its Mediators in Acute Ischemic Stroke

Jin, R., Liu, L., Zhang, S., Nanda, A., & Li, G. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9508-6 · Cited by 422

Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice

Combadière, C., Potteaux, S., Gao, J.-L., Esposito, B., Casanova, S., Lee, E. J., Debré, P., Tedgui, A., Murphy, P. M., & Mallat, Z. (2003) · Circulation · doi:10.1161/01.cir.0000057548.68243.42 · Cited by 476

Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage

Taylor, R. A., & Sansing, L. H. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/746068 · Cited by 410

The innate immune response in ischemic acute kidney injury

Jang, H. R., & Rabb, H. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.016 · Cited by 357

Microglia and ischemic stroke: a double-edged sword.

Patel, A. R., Ritzel, R. M., McCullough, L. D., & Liu, F. (2013) · Europe PMC (PubMed Central) · Cited by 363

The dual role of the neuroinflammatory response after ischemic stroke: Modulatory effects of hypothermia

Ceulemans, A.-G., Zgavc, T., Kooijman, R., Hachimi-Idrissi, S., Sarre, S., & Michotte, Y. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-74 · Cited by 351

Neuron–glia crosstalk in health and disease: fractalkine and CX 3 CR1 take centre stage

Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 358

Inflammation and brain injury: Acute cerebral ischaemia, peripheral and central inflammation

Dénes, Á., Thornton, P., Rothwell, N. J., & Allan, S. M. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.09.010 · Cited by 307

Microglia in Health and Disease

Ransohoff, R. M., & Khoury, J. E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020560 · Cited by 303

Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles

Dabrowska, S., Andrzejewska, A., Łukomska, B., & Janowski, M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1571-8 · Cited by 304

Perforin-Dependent Brain-Infiltrating Cytotoxic CD8+ T Lymphocytes Mediate Experimental Cerebral Malaria Pathogenesis

Nitcheu, J., Bonduelle, O., Combadière, C., Tefit, M., Seilhean, D., Mazier, D., & Combadière, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2221 · Cited by 288

Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans

McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M. G., Cupples, L. A., Merrell, M. N., Wilson, P. W. F., D’Agostino, R. B., O’Donnell, C. J., Patel, D. D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16790 · Cited by 285

In vivo structure/function and expression analysis of the CX3C chemokine fractalkine

Kim, K.-W., Vallon-Eberhard, A., Zigmond, E., Farache, J., Shezen, E., Shakhar, G., Ludwig, A., Lira, S. A., & Jung, S. (2011) · Blood · doi:10.1182/blood-2011-04-348946 · Cited by 299

Chemokines in ischemia and reperfusion

Frangogiannis, N. G. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0022 · Cited by 276

Role of CX3CR1 (Fractalkine Receptor) in Brain Damage and Inflammation Induced by Focal Cerebral Ischemia in Mouse

Dénes, Á., Ferenczi, S., Halász, J., Környei, Z., & Kovács, K. J. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.64 · Cited by 276

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders

Pawelec, P., Ziemka‐Nałęcz, M., Sypecka, J., & Zalewska, T. (2020) · Cells · doi:10.3390/cells9102277 · Cited by 284

Inflammatory Responses in Brain Ischemia

Kawabori, M., & Yenari, M. A. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209154036 · Cited by 273

Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes

Mecca, C., Giambanco, I., Donato, R., & Arcuri, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010318 · Cited by 258

Shaping Neuronal Fate: Functional Heterogeneity of Direct Microglia-Neuron Interactions

Cserép, C., Pósfai, B., & Dénes, Á. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.007 · Cited by 256

The role of microglia and myeloid immune cells in acute cerebral ischemia

Benakis, C., García‐Bonilla, L., Iadecola, C., & Anrather, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00461 · Cited by 259

Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets

Kim, J. Y., Kawabori, M., & Yenari, M. A. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131228205146 · Cited by 253

Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke

Lopes Pinheiro, M. A., Kooij, G., Mizee, M. R., Kamermans, A., Enzmann, G., Lyck, R., Schwaninger, M., Engelhardt, B., & de Vries, H. E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.018 · Cited by 247

The Ischemic Environment Drives Microglia and Macrophage Function

Fumagalli, S., Perego, C., Pischiutta, F., Zanier, E. R., & Simoni, M. G. D. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00081 · Cited by 261

Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke

Mizuma, A., & Yenari, M. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00467 · Cited by 228

Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages

Donnelly, D. J., Longbrake, E. E., Shawler, T. M., Kigerl, K. A., Lai, W., Tovar, C. A., Ransohoff, R. M., & Popovich, P. G. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2114-11.2011 · Cited by 219

Chemokines and Glial Cells: A Complex Network in the Central Nervous System

Ambrosini, E., & Aloisi, F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000021246.96864.89 · Cited by 221

Rational modulation of the innate immune system for neuroprotection in ischemic stroke

Amantea, D., Micieli, G., Tassorelli, C., Cuartero, M. I., Ballesteros, I., Certo, M., Moro, M. Á., Lizasoaín, I., & Bagetta, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00147 · Cited by 224

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling

Limatola, C., & Ransohoff, R. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00229 · Cited by 210

CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells

Ancuța, P., Wang, J., & Gabuzda, D. H. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206125 · Cited by 210

CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases

Subbarayan, M. S., Joly‐Amado, A., Bickford, P. C., & Nash, K. R. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107989 · Cited by 204

Fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway attentuates microglial activation in vivo and in vitro

Lyons, A., Lynch, A. M., Downer, E. J., Hanley, R., O’Sullivan, J. B., Smith, A., & Lynch, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06253.x · Cited by 202

Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide

Corona, A. W., Huang, Y., O’Connor, J. C., Dantzer, R., Kelley, K. W., Popovich, P. G., & Godbout, J. P. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-93 · Cited by 206

Microglia in cerebral ischemia: molecular actions and interactionsThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigator's Forum.

Lai, A. Y., & Todd, K. G. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-143 · Cited by 202

CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents

Cipriani, R., Villa, P., Chece, G., Lauro, C., Paladini, A., Micotti, E., Perego, C., De Simoni, M.-G., Fredholm, B. B., Eusebi, F., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3611-11.2011 · Cited by 166

Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root

Teupser, D., Pavlides, S., Tan, M., Gutierrez-Ramos, J.-C., Kolbeck, R., & Breslow, J. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408096101 · Cited by 192

Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction

Haas, A. H. D., van Weering, H. R. J., de Jong, E. K., Boddeke, H. W. G. M., & Biber, K. P. H. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0036-8 · Cited by 187

CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice

Fumagalli, S., Perego, C., Ortolano, F., & Simoni, M. G. D. (2013) · Glia · doi:10.1002/glia.22474 · Cited by 189

Transmembrane chemokines: Versatile ‘special agents’ in vascular inflammation

Weber, C., & Ludwig, A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0035 · Cited by 175

Neuro-immune crosstalk in CNS diseases

Kerschensteiner, M., Meinl, E., & Hohlfeld, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.009 · Cited by 162

Chemokines in CNS injury and repair

Järve, A., & Müller, H. W. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1427-3 · Cited by 160

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity

Limatola, C., Lauro, C., Catalano, M., Ciotti, M. T., Bertollini, C., Di Angelantonio, S., Ragozzino, D., & Eusebi, F. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.03.023 · Cited by 153

Mechanisms of leukocyte migration across the blood-retina barrier

Crane, I. J., & Liversidge, J. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0106-7 · Cited by 152

The emerging role for chemokines in epilepsy

Fabene, P. F., Bramanti, P., & Constantin, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.016 · Cited by 154

Primary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration

Neher, J. J., Neniškytė, U., & Brown, G. C. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00027 · Cited by 157

Smooth Muscle Cells in Human Atherosclerotic Plaques Express the Fractalkine Receptor CX 3 CR1 and Undergo Chemotaxis to the CX 3 C Chemokine Fractalkine (CX 3 CL1)

Lucas, A., Bursill, C. A., Guzik, T. J., Sadowski, J., Channon, K. M., & Greaves, D. R. (2003) · Circulation · doi:10.1161/01.cir.0000097119.57756.ef · Cited by 154

Neuroinflammation and fractalkine signaling in Alzheimer’s disease

Finneran, D. J., & Nash, K. R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1412-9 · Cited by 132

Role of microglia in stroke

Planas, A. M. (2024) · Glia · doi:10.1002/glia.24501 · Cited by 144

Alzheimer's Mechanisms in Ischemic Brain Degeneration

Pluta, R. M., Ułamek, M., & Jabłoński, M. (2009) · The Anatomical Record · doi:10.1002/ar.21018 · Cited by 134

Fractalkine Signaling and Microglia Functions in the Developing Brain

Arnoux, I., & Audinat, É. (2015) · Neural Plasticity · doi:10.1155/2015/689404 · Cited by 136

Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion

Schäfer, A., Schulz, C., Eigenthaler, M., Fraccarollo, D., Kobsar, A. L., Gawaz, M., Ertl, G., Walter, U., & Bauersachs, J. K. (2003) · Blood · doi:10.1182/blood-2002-10-3260 · Cited by 132

Neuroinflammation and Neuroimmune Dysregulation after Acute Hypoxic-Ischemic Injury of Developing Brain

Bhalala, U. S., Koehler, R. C., & Kannan, S. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00144 · Cited by 133

CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin

Sunnemark, D., Eltayeb, S., Nilsson, M., Wallström, E., Lassmann, H., Olsson, T. P., Berg, A., & Ericsson‐Dahlstrand, A. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-17 · Cited by 125

The Role of Microglia in Modulating Neuroinflammation after Spinal Cord Injury

Brockie, S. T., Hong, J., & Fehlings, M. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189706 · Cited by 122

Adenosine A1 Receptors and Microglial Cells Mediate CX3CL1-Induced Protection of Hippocampal Neurons Against Glu-Induced Death

Lauro, C., Cipriani, R., Catalano, M., Trettel, F., Chece, G., Brusadin, V., Antonilli, L., van Rooijen, N., Eusebi, F., Fredholm, B. B., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.26 · Cited by 105

Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents

Poniatowski, Ł. A., Wojdasiewicz, P., Krawczyk, M., Szukiewicz, D., Gasik, R., Kubaszewski, Ł., & Kurkowska‐Jastrzębska, I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9787-4 · Cited by 107

Analyses of phenotypic and functional characteristics of CX3CR1‐expressing natural killer cells

Hamann, I., Unterwalder, N., Cardona, A. E., Meisel, C., Zipp, F., Ransohoff, R. M., & Infante‐Duarte, C. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03409.x · Cited by 102

Inflammation in Ischemic Stroke: Mechanisms, Consequences and Possible Drug Targets

Ahmad, M., Dar, N. J., Bhat, Z. S., Hussain, A., Shah, A., Liu, H., & Graham, S. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023094720 · Cited by 102

MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling

Mao, M., Xu, Y., Zhang, X., Yang, L. C., An, X., Qu, Y., Chai, Y.-N., Wang, Y.-R., Li, T., & Ai, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01919-w · Cited by 100

Brain Cytokines and Chemokines: Roles in Ischemic Injury and Pain

Minami, M., Katayama, T., & Satoh, M. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj06005x · Cited by 100

The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects

Thuc, O. L., Blondeau, N., Nahon, J., & Rovère, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12855 · Cited by 105

TGF-β1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia

Chen, S., Luo, D., Streit, W. J., & Harrison, J. K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00354-5 · Cited by 96

Induction of Immunologic Tolerance to Myelin Basic Protein Prevents Central Nervous System Autoimmunity and Improves Outcome After Stroke

Gee, J. M., Kalil, A., Thullbery, M., & Becker, K. J. (2008) · Stroke · doi:10.1161/strokeaha.107.501486 · Cited by 96

CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system

Kastenbauer, S. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00085-7 · Cited by 98

Fractalkine receptor deficiency is associated with early protection but late worsening of outcome following brain trauma in mice

Zanier, E. R., Marchesi, F., Ortolano, F., Perego, C., Arabian, M., Zoerle, T., Sammali, E., Pischiutta, F., & De Simoni, M.-G. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4041 · Cited by 94

Fractalkine protein localization and gene expression in mouse brain

Tarozzo, G., Bortolazzi, S., Crochemore, C., Chen, S. ‐., Lira, A. S., Abrams, J. S., & Beltramo, M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10645 · Cited by 105

CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke

Stowe, A. M., Wacker, B. K., Cravens, P. D., Perfater, J. L., Li, M. K., Hu, R., Freie, A. B., Stüve, O., & Gidday, J. M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-33 · Cited by 91

Role of CX3CL1 in Diseases

Liu, W., Jiang, L., Bian, C., Liang, Y., Xing, R., Yishakea, M., & Dong, J. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0395-9 · Cited by 92

Inflammation After Stroke: Mechanisms and Therapeutic Approaches

Ahmad, M., & Graham, S. H. (2010) · Translational Stroke Research · doi:10.1007/s12975-010-0023-7 · Cited by 88

CX3CL1/CX3CR1-Mediated Microglia Activation Plays a Detrimental Role in Ischemic Mice Brain via p38MAPK/PKC Pathway

Liu, Y., Wu, X.-M., Luo, Q.-Q., Huang, S., Yang, Q.-W. Q., Wang, F.-X., Ke, Y., & Qian, Z.-M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.97 · Cited by 84

Inflammation as Therapeutic Objective in Stroke

Jordán, J., Segura, T., Brea, D., Galindo, M. F., & Castillo, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786848766 · Cited by 83

NEW evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease

Shan, S., Hong-Min, T., Yi, F., Jun-Peng, G., Yue, F. L., Yan-hong, T., Yun-ke, Y., Li, W., Wang, X., Ma, J., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.004 · Cited by 82

Role of Fractalkine/CX3CR1 Interaction in Light-Induced Photoreceptor Degeneration through Regulating Retinal Microglial Activation and Migration

Zhang, M., Xu, G., Liu, W. D., Ni, Y., & Zhou, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035446 · Cited by 80

Herbal Medicines for Ischemic Stroke: Combating Inflammation as Therapeutic Targets

Gu, Y., Chen, J., & Shen, J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9525-5 · Cited by 78

Repopulation of cochlear macrophages in murine hematopoietic progenitor cell chimeras: The role of CX3CR1

Sato, E., Shick, H. E., Ransohoff, R. M., & Hirose, K. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21583 · Cited by 80

Detrimental effect of fractalkine on myocardial ischaemia and heart failure

Xuan, W., Liao, Y., Chen, B., Huang, Q., Xu, D., Liu, Y., Bin, J., & Kitakaze, M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr221 · Cited by 82

Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5

Sorce, S., Bonnefont, J., Julien, S., Marq‐Lin, N., Rodríguez, I., Dubois‐Dauphin, M., & Krause, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00697.x · Cited by 79

An engineered CX3CR1 antagonist endowed with anti-inflammatory activity

Dorgham, K., Ghadiri, A., Hermand, P., Rodero, M. P., Poupel, L., Iga, M., Hartley, O., Gorochov, G., Combadière, C., & Déterre, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0308158 · Cited by 82

Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery

Xing, C., & Lo, E. H. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.004 · Cited by 76

Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak–Stat5 Pathway

Yang, X. P., Mattagajasingh, S. N., Su, S., Chen, G., Cai, Z. P., Fox-Talbot, K., Irani, K., & Becker, L. C. (2007) · Circulation Research · doi:10.1161/circresaha.107.160812 · Cited by 72

Inflammation Mediated Epileptogenesis as Possible Mechanism Underlying Ischemic Post-stroke Epilepsy

Tröscher, A. R., Gruber, J., Wagner, J. N., Böhm, V., Wahl, A.-S., & von Oertzen, T. J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.781174 · Cited by 66

Immunomodulatory Therapeutic Strategies in Stroke

Malone, K., Amu, S., Moore, A., & Waeber, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00630 · Cited by 71

Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators

Lee, S.-R., Guo, S., Scannevin, R. H., Magliaro, B. C., Rhodes, K. J., Wang, X., & Lo, E. H. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.017 · Cited by 66

Chemokines play complex roles in cerebral ischemia

Chen, C., Chu, S., Liu, D., Zhang, Z., Kong, L., Zhou, X., & Chen, N. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.06.008 · Cited by 64

Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.

Gemma, C., Bachstetter, A. D., & Bickford, P. C. (2010) · Europe PMC (PubMed Central) · Cited by 62

Inflammation in adult and neonatal stroke

Vexler, Z. S., Tang, X. N., & Yenari, M. A. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.008 · Cited by 63

CX3CL1 inhibits NLRP3 inflammasome-induced microglial pyroptosis and improves neuronal function in mice with experimentally-induced ischemic stroke

Ge, Y., Wang, L., Wang, C., Chen, J., Dai, M., Yao, S., & Lin, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120564 · Cited by 61

Fractalkine reduces N‐methyl‐ d ‐aspartate‐induced calcium flux and apoptosis in human neurons through extracellular signal‐regulated kinase activation

Deiva, K., Geeraerts, T., Salim, H., Leclerc, P., Héry, C., Hugel, B., Freyssinet, J., & Tardieu, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03800.x · Cited by 61

Therapeutic potential of the chemokine–receptor duo fractalkine/CX3CR1: an update

D’Haese, J. G., Friess, H., & Ceyhan, G. O. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.682574 · Cited by 63

Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death

Rosito, M., Lauro, C., Chece, G., Porzia, A., Monaco, L., Mainiero, F., Catalano, M., Limatola, C., & Trettel, F. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00193 · Cited by 63

Expression changes in fractalkine induced by focal cerebral ischemia and reperfusion in rats

Zhou, M., Fan, X., & Yan, L. (2015) · Zhonghua laonian yixue zazhi · doi:10.3760/cma.j.issn.0254-9026.2015.04.024

Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia‐reperfusion brain injury in the rat

Tarozzo, G., Campanella, M., Ghiani, M., Bulfone, A., & Beltramo, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02007.x · Cited by 154

Role of CX3CR1 (Fractalkine Receptor) in Brain Damage and Inflammation Induced by Focal Cerebral Ischemia in Mouse

Dénes, Á., Ferenczi, S., Halász, J., Környei, Z., & Kovács, K. J. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.64 · Cited by 276

Expression of a novel chemokine,Fractalkine,in Myocardial Ischemia-reperfusion Injury

Liu, Y. (2007) · Chinese Journal of Hypertension

First steps towards a targeted immunomodulatory therapy in patients with recurrent miscarriage and elevated natural killer cells

Kuon, R., Müller, F., Vomstein, K., Weber, M., Markert, U. R., Strowitzki, T., Daniel, V., & Tóth, B. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.04.022